Yamo Pharmaceuticals has a total of 28 patents globally, out of which 14 have been granted. Of these 28 patents, more than 78% patents are active. The United States is where Yamo Pharmaceuticals has filed the maximum number of patents. Parallelly, the United States seems to be the main focused R&D center of Yamo Pharmaceuticals and is also the origin country of the firm.
Yamo Pharmaceuticals was founded in the year 2015. The company is a clinical-stage pharmaceutical firm that develops L1-79, a novel therapy for Autism spectrum disorder.
Do read about some of the most popular patents of Yamo Pharmaceuticals which have been covered by us in this article and also you can find Yamo Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Yamo Pharmaceuticals patent portfolio.
How many patents does Yamo Pharmaceuticals have?
Yamo Pharmaceuticals has a total of 28 patents globally. These patents belong to 7 unique patent families. Out of 28 patents, 22 patents are active.
How Many Patents did Yamo Pharmaceuticals File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Yamo Pharmaceuticals Applications Filed | Yamo Pharmaceuticals Patents Granted |
| 2022 | 2 | 2 |
| 2021 | 2 | – |
| 2020 | 3 | 3 |
| 2019 | 9 | 2 |
| 2018 | 4 | 1 |
| 2017 | 2 | 2 |
| 2016 | 2 | 2 |
| 2015 | 1 | – |
| 2014 | 1 | – |
How many Yamo Pharmaceuticals patents are Alive/Dead?
Worldwide Patents
How Many Patents did Yamo Pharmaceuticals File in Different Countries?
Countries in which Yamo Pharmaceuticals Filed Patents
| Country | Patents |
| United States Of America | 20 |
| Australia | 2 |
| Europe | 2 |
| India | 2 |
Where are Research Centres of Yamo Pharmaceuticals Patents Located?
The R&D Centre of Yamo Pharmaceuticals is in the US.
10 Best Yamo Pharmaceuticals Patents
US9326962B2 is the most popular patent in the Yamo Pharmaceuticals portfolio. It has received 16 citations so far from companies like Hoffman Technologies.
Below is the list of 10 most cited patents of Yamo Pharmaceuticals:
| Publication Number | Citation Count |
| US9326962B2 | 16 |
| US9308188B2 | 14 |
| US10085959B2 | 9 |
| US9763903B2 | 7 |
| US9757348B2 | 7 |
| US10517845B2 | 6 |
| US20190298677A1 | 3 |
| US10857118B2 | 2 |
| US10751313B2 | 2 |
| WO2020018292A1 | 2 |
List of Yamo Pharmaceuticals Patents
| Yamo Pharmaceuticals Patents | Title |
| US11786496B2 | Composition And Methods For Treating Intestinal Hyperpermeability |
| US11633372B2 | Compositions And Methods For Treating Autism |
| US11446268B2 | Compositions And Methods For Treating Anxiety-Related Disorders |
| US11351136B2 | Compositions And Methods For Treating Retinopathy |
| US10857118B2 | Compositions And Methods For Treating Intestinal Hyperpermeability |
| US10813901B2 | Compositions And Methods For Treating Autism |
| US10751313B2 | Compositions And Methods For Treating Autism |
| US10517845B2 | Compositions And Methods For Treating Intestinal Hyperpermeability |
| US10426836B2 | Compositions And Methods For Treating Stress-Related Disorders |
| US10085959B2 | Compositions And Methods For Treating Intestinal Hyperpermeability |
| US9763903B2 | Compositions And Methods For Treating Intestinal Hyperpermeability |
| US9757348B2 | Composition And Methods For Treating Intestinal Hyperpermeability |
| US9326962B2 | Compositions And Methods For Treating Intestinal Hyperpermeability |
| US9308188B2 | Compositions And Methods For Treating Intestinal Hyperpermeability |
| US20230310358A1 | Compositions And Methods For Treating Autism |
| US20230141609A1 | Methods Of Treating Amyotrophic Lateral Sclerosis And Symptoms |
| US20230040681A1 | Compositions And Methods For Treating Anxiety-Related Disorders |
| US20220288003A1 | Compositions And Methods For Treating Retinopathy |
| US20210338619A1 | Compositions And Methods For Treating Autism |
| EP3823593A4 | Compositions And Methods For Treating Autism |
| AU2019308501A1 | Compositions And Methods For Treating Autism |
| AU2019306092A1 | Compositions And Methods For Treating Autism |
| US20190298677A1 | Methods Of Treating Amyotrophic Lateral Sclerosis And Symptoms |
| EP3823626A4 | Compositions And Methods For Treating Autism |
| WO2020018292A1 | Compositions And Methods For Treating Autism |
| WO2020018291A1 | Compositions And Methods For Treating Autism |
| IN202117002867A | Compositions And Methods For Treating Autism |
| IN202117002865A | Compositions And Methods For Treating Autism |
What are Yamo Pharmaceuticals’ key innovation segments?
What Technologies are Covered by Yamo Pharmaceuticals?
The chart below distributes patents filed by Yamo Pharmaceuticals